Výsledky vyhledávání - "Gesolfo, C. Scalici"

Akademický článek

SC177 - Radium-223 in bone metastatic castration resistant prostate cancer. Should we always treat the prostate primary tumour?

Autor: Serretta, V., Costa, R., Princiotta, A., Gesolfo, C. Scalici, Borsellino, N., Verderame, F., Valerio, R., Gebbia, V., Morabito, A., Tripoli, V., Licari, M., Sanfilippo, C.

Publikováno v: In European Urology Supplements October 2019 18(9):e3263-e3263

Zobrazit plný text záznamu

Akademický článek

SC70 - The feasibility and prognostic value of sequential evaluation of EGFR cell expression in bladder washings after transurethral resection of Non-Muscle Invasive Bladder Cancer: A new potential tool to identify patients at higher risk of disease progression

Autor: Di Maida, F., Mari, A., Gesolfo, C. Scalici, Cangemi, A., Tellini, R., Sforza, S., Cocci, A., Allegro, R., Masieri, L., Russo, A., Carini, M., Minervini, A., Serretta, V.

Publikováno v: In European Urology Supplements October 2019 18(9):e3200-e3200

Zobrazit plný text záznamu

409 Fibronectin (FN), epidermal growth factor-receptor (EGF-R) and heparin-binding epidermal growth factor-like (HB-EGF) urinary expressions and topical toxicity of adjuvant intravesical therapy for non muscle invasive bladder cancer (NMI-BC)

Autor: F. Torretta, Vincenzo Serretta, Vincenza Alonge, Gesolfo C. Scalici, S. Caruso, Fiorentino E, Antonio Russo, G. Carità

Publikováno v: European Urology Supplements. 13:e409

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1a3e7807678108ed5d64e2a0e5462570
https://doi.org/10.1016/s1569-9056(14)60404-8

Zobrazit plný text záznamu